ArticleBMC cancer2024

DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol.

Cassandra White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.